United States: MDL Panel Grants Transfer Of Aflibercept BPCIA Case - Goodwin Procter LLP

As we previously reported, on January 11, 2024, Regeneron Pharmaceuticals, Inc. ("Regeneron") moved to establish a multi-district litigation ("MDL") for its aflibercept BPCIA litigation...